Neueste Storys

Debiopharm International SA

Debiopharm Partners with Genedata to Digitalize Translational Research

Basel, Switzerland (ots) - Pioneer in advancing tomorrow’s standard of care to cure cancer and infectious diseases, Debiopharm selects Genedata Profiler, an industry-leading digital platform for translational and reverse translational research, as the cornerstone of its research and development strategy. Genedata, the leading provider of enterprise software solutions ...

Kunstmuseum St.Gallen

7

Camille Henrot – Sweet Days of Discipline |10 June – 5 November 2023, LOK

Schweizerischer Nationalfonds / Fonds national suisse

1,500 new research projects and 400 fellowships abroad in anniversary year

Bern (ots) - In 2022, the SNSF approved 910 million francs for its regular funding schemes. We awarded a further 173 million for the Horizon Europe transitional measures. Coronavirus research generated a wealth of knowledge. On 1 August 2022, the SNSF celebrated its 70th anniversary. Founded in 1952 out of concern that Swiss research might sink into mediocrity after ...

INFOSYS

Launched today: Infosys Topaz - An AI-first offering to accelerate business value for global enterprises using generative AI

Bengaluru, India (ots/PRNewswire) - - 12,000+ AI use cases, 150+ pre-trained AI models and 10+ AI platforms steered by AI-first specialists and data strategists - 'Responsible by design' approach ensures uncompromising ethics, trust, privacy, security and compliance Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a ...

Grünenthal Group

Grünenthal’s resiniferatoxin receives Breakthrough Therapy Designation from U.S. FDA for pain associated with osteoarthritis of the knee

Aachen (ots) - - Knee osteoarthritis is a progressive condition affecting over 360 million people worldwide and may have severe symptoms, including pain. - Grünenthal is running a global Phase III programme to investigate the efficacy and safety of intra-articular injections of resiniferatoxin, a non-opioid ...

Imagry

Continental Integrates Imagry's Autonomous Driving Technology to Support Automated Parking for Mass Market Passenger Cars

Haifa, Israel (ots/PRNewswire) - - Solution automates parking spot exploration - Once a suitable parking spot has been identified by the system the vehicle will park autonomously, using Continental's and Imagry's technology - Function designed for use in both covered parking garages and uncovered parking lots - ...

Imagry

Continental Integrates Imagery's Autonomous Driving Technology to Support Automated Parking for Mass Market Passenger Cars

Haifa, Israel (ots/PRNewswire) - - Solution automates parking spot exploration - Once a suitable parking spot has been identified by the system the vehicle will park autonomously, using Continental's and Imagery's technology - Function designed for use in both covered parking garages and uncovered parking lots - ...

Norgine B.V.

European study highlights need to improve the quality of conversations about induction of labour (IoL) in clinical settings

Amsterdam (ots/PRNewswire) - - Almost 1 in 2 women (49%) felt the experience of IoL differed from their expectations - The majority of expectant mothers (65%) did not feel fully involved in choosing which method of IoL they prefer - Findings emphasize the importance of collaborative decision-making between ...

Debiopharm International SA

DEBIOPHARM LAUNCHES PHASE 1/2 COMBINATION TRIAL INVESTIGATING BRAIN-PENETRANT SELECTIVE WEE1 INHIBITOR FOR BRAIN CANCER PATIENTS

Lausanne (ots) - - Glioblastomas (GBM) are among the most aggressive and lethal tumors of the central nervous system with a 5-year survival rate of only 6.8%. - Debiopharm is combining its potent, brain penetrant WEE1 inhibitor Debio 0123 with standard of care (SOC) therapy. Debio 0123 hopes to hinder DNA damage ...

Akkodis

Akkodis - Development partner for BMW i Vision Dee concept car

Zurich (ots/PRNewswire) - As an integral part of the development of the drivable concept car, Akkodis, a global leader in the Smart Industry, contributed its technical and digital expertise to the BMW i Vision Dee. Akkodis, part of the Adecco Group, has joined forces with the BMW Group to develop and produce the BMW i Vision Dee. Earlier this year, the BMW Group unveiled the BMW i Vision Dee to a global audience during ...

Masdar, the Abu Dhabi Future Energy Company

Masdar and Airbus sign agreement to support development and growth of global sustainable aviation fuel market

Abu Dhabi, Uae (ots/PRNewswire) - - Use of sustainable aviation fuel estimated to reduce greenhouse gas emissions by up to 95 percent compared to existing jet fuel Abu Dhabi Future Energy Company PJSC – Masdar, one of the world's leading clean energy companies, has signed an agreement with Airbus, the largest ...

CSI Christian Solidarity International

Save Karabakh Coalition calls on Switzerland to act to protect besieged Armenians

INFOSYS

Infosys and bp Deepen their Relationship to Transform bp's Digital Application Landscape

Bengaluru, India (ots/PRNewswire) - - Modernize end-to-end application services to enhance operational efficiencies and business resilience - Build adaptive, agile and AI-amplified processes to accelerate innovation Infosys (NSE: INFY) (BSE:INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting and bp, a global integrated energy company, ...

Schweizerischer Nationalfonds / Fonds national suisse

Transition to a sustainable economy: policy recommendations

Bern (ots) - How can economic progress be aligned with social and environmental responsibility? In closing, the National Research Programme "Sustainable Economy" (NRP 73) presents recommendations in this regard. To mark its conclusion, the National Research Programme "Sustainable Economy: resource-efficient, future-oriented, innovative" (NRP 73) is presenting a white paper with recommendations to policymakers for the ...

Swissmem

Technology industry: subdued outlook for 2023

Zurich (ots) - The business situation in the Swiss technology industry (mechanical and electrical engineering industries and related technology sectors) is currently still good. Both sales (+4.9%) and exports (+2.8%) rose in the first quarter of 2023 compared with the previous year. However, the decline in new orders in the first quarter (-4.8%) and the low worldwide Purchasing Managers' Index (PMI) indicate considerably ...

China Matters

China Matters' Feature: What Makes Ningbo-CEEC Connection Vibrant?

Euro Airport Basel-Mulhouse-Freiburg

Ascension and Pentecost 2023: travel at ease thanks to a good preparation

Selecta Group

4

Selecta FoodTech-Solutions

FDI World Dental Federation

FDI WORLD DENTAL FEDERATION'S VIRTUAL SUMMIT ON WORLD ENVIRONMENT DAY TO HIGHLIGHT SUSTAINABLE DENTAL PRACTICES FOR A GREENER FUTURE

Kunstmuseum St.Gallen

2

Haris Epaminonda, 8 July 2023 – 14 January 2024, Kunstmuseum St. Gallen

CROMA-PHARMA GmbH

Croma-Pharma receives marketing authorisation for Letybo® in a further 12 European markets

Vienna (ots/PRNewswire) - Croma (Croma-Pharma® GmbH) announced today that it has received marketing authorisation for Letybo®, the company's botulinum toxin product, in 12 additional European markets. These include Belgium, Cyprus, Czech Republic, Denmark, Finland, Greece, Hungary, Luxembourg, Malta, Norway, Slovakia and Sweden. Letybo® will be launched in these ...

CROMA-PHARMA GmbH

/C O R R E C T I O N -- Croma-Pharma/

Vienna (ots/PRNewswire) - In the news release, Croma-Pharma reports 27% revenue growth in 2022 and targets further revenue growth in 2023 and thereafter, issued 09-May-2023 by Croma-Pharma over PR Newswire, we are advised by the company that the footnote [1] has been updated. The complete, corrected release follows: Croma-Pharma reports 27% revenue growth in 2022 and targets further revenue growth in 2023 and thereafter - ...

CROMA-PHARMA GmbH

Croma-Pharma reports 27% revenue growth in 2022 and targets further revenue growth in 2023 and thereafter

Vienna (ots/PRNewswire) - - Company reports strong financial results for 2022 with 27% revenue growth in 2022 and significantly increased margins - Growth driven by launch of Letybo® and its catalytic effect on the existing portfolio as well as strong market growth - Continued market share gains, strategic mid-term ...

Lysando AG

Amicogen and Lysando: Novel approach for the treatment of mastitis in dairy cows